These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 22220692)
1. High-yield platelet units revealed immediate pH decline and delayed mitochondrial dysfunction during storage in 100% plasma as compared with storage in SSP+. Sandgren P; Stjepanovic A Vox Sang; 2012 Jul; 103(1):55-63. PubMed ID: 22220692 [TBL] [Abstract][Full Text] [Related]
2. Buffy-coat platelet variables and metabolism during storage in additive solutions or plasma. Zhang JG; Carter CJ; Culibrk B; Devine DV; Levin E; Scammell K; Weiss S; Gyongyossy-Issa MI Transfusion; 2008 May; 48(5):847-56. PubMed ID: 18298601 [TBL] [Abstract][Full Text] [Related]
3. Periods without agitation diminish platelet mitochondrial function during storage. Skripchenko A; Myrup A; Thompson-Montgomery D; Awatefe H; Moroff G; Wagner SJ Transfusion; 2010 Feb; 50(2):390-9. PubMed ID: 19874561 [TBL] [Abstract][Full Text] [Related]
4. Mitochondrial dysfunction of platelets stored in first- and second-generation containers is, in part, associated with elevated carbon dioxide levels. Skripchenko A; Myrup A; Thompson-Montgomery D; Awatefe H; Wagner SJ Transfusion; 2011 Feb; 51(2):371-9. PubMed ID: 20796252 [TBL] [Abstract][Full Text] [Related]
5. In vitro storage characteristics of platelet concentrates suspended in 70% SSP+(TM) additive solution versus plasma over a 14-day storage period. Saunders C; Rowe G; Wilkins K; Holme S; Collins P Vox Sang; 2011 Aug; 101(2):112-21. PubMed ID: 21414010 [TBL] [Abstract][Full Text] [Related]
6. In vitro variables of apheresis platelets are stably maintained for 7 days with 5% residual plasma in a glucose and bicarbonate salt solution, PAS-5. Radwanski K; Wagner SJ; Skripchenko A; Min K Transfusion; 2012 Jan; 52(1):188-94. PubMed ID: 21790624 [TBL] [Abstract][Full Text] [Related]
7. Maintenance of platelet in vitro properties during 7-day storage in M-sol with a 30-hour interruption of agitation. Wagner SJ; Myrup A; Awatefe H; Thompson-Montgomery D; Hirayama J; Skripchenko A Transfusion; 2008 Dec; 48(12):2501-607. PubMed ID: 18764828 [TBL] [Abstract][Full Text] [Related]
8. In vitro effects on platelets irradiated with short-wave ultraviolet light without any additional photoactive reagent using the THERAFLEX UV-Platelets method. Sandgren P; Tolksdorf F; Struff WG; Gulliksson H Vox Sang; 2011 Jul; 101(1):35-43. PubMed ID: 21175668 [TBL] [Abstract][Full Text] [Related]
9. Storage of buffy-coat-derived platelets in additive solutions: in vitro effects on platelets stored in reformulated PAS supplied by a 20% plasma carry-over. Sandgren P; Mayaudon V; Payrat JM; Sjödin A; Gulliksson H Vox Sang; 2010 Apr; 98(3 Pt 2):415-22. PubMed ID: 19788514 [TBL] [Abstract][Full Text] [Related]
10. Platelet capacity of various platelet pooling systems for buffy coat-derived platelet concentrates. Dijkstra-Tiekstra MJ; Kuipers W; Setroikromo AC; de Wildt-Eggen J Transfusion; 2008 Oct; 48(10):2114-21. PubMed ID: 18647365 [TBL] [Abstract][Full Text] [Related]
11. Cell quality of apheresis-derived platelets treated with riboflavin-ultraviolet light after resuspension in platelet additive solution. Picker SM; Tauszig ME; Gathof BS Transfusion; 2012 Mar; 52(3):510-6. PubMed ID: 21981030 [TBL] [Abstract][Full Text] [Related]
12. In vitro quality of platelets during prolonged storage after washing with three platelet additive solutions. Tynngård N; Trinks M; Berlin G Vox Sang; 2012 Jan; 102(1):32-9. PubMed ID: 21534983 [TBL] [Abstract][Full Text] [Related]
13. A rest period before agitation may improve some in vitro apheresis platelet parameters during storage. Skripchenko A; Myrup A; Awatefe H; Thompson-Montgomery D; Wagner SJ Transfusion; 2012 Jul; 52(7):1433-8. PubMed ID: 22211457 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of platelet mitochondria integrity after treatment with Mirasol pathogen reduction technology. Li J; Lockerbie O; de Korte D; Rice J; McLean R; Goodrich RP Transfusion; 2005 Jun; 45(6):920-6. PubMed ID: 15934990 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of in vitro storage properties of prestorage pooled whole blood-derived platelets suspended in 100 percent plasma and treated with amotosalen and long-wavelength ultraviolet light. Wagner SJ; Skripchenko A; Myrup A; Awatefe H; Thompson-Montgomery D; Moroff G; Carmichael P; Lin L Transfusion; 2009 Apr; 49(4):704-10. PubMed ID: 19171001 [TBL] [Abstract][Full Text] [Related]
16. The role of bicarbonate in platelet additive solution for apheresis platelet concentrates stored with low residual plasma. Radwanski K; Min K Transfusion; 2013 Mar; 53(3):591-9. PubMed ID: 22725609 [TBL] [Abstract][Full Text] [Related]
17. Implementation of the INTERCEPT Blood System for Platelets into routine blood bank manufacturing procedures: evaluation of apheresis platelets. Janetzko K; Lin L; Eichler H; Mayaudon V; Flament J; Klüter H Vox Sang; 2004 May; 86(4):239-45. PubMed ID: 15144528 [TBL] [Abstract][Full Text] [Related]
18. Riboflavin and UV light treatment of platelets: a protective effect of platelet additive solution? van der Meer PF; Bontekoe IJ; Daal BB; de Korte D Transfusion; 2015 Aug; 55(8):1900-8. PubMed ID: 25752624 [TBL] [Abstract][Full Text] [Related]
19. Functional characteristics of apheresis-derived platelets treated with ultraviolet light combined with either amotosalen-HCl (S-59) or riboflavin (vitamin B2) for pathogen-reduction. Picker SM; Oustianskaia L; Schneider V; Gathof BS Vox Sang; 2009 Jul; 97(1):26-33. PubMed ID: 19302416 [TBL] [Abstract][Full Text] [Related]
20. Cell viability during platelet storage in correlation to cellular metabolism after different pathogen reduction technologies. Picker SM; Schneider V; Oustianskaia L; Gathof BS Transfusion; 2009 Nov; 49(11):2311-8. PubMed ID: 19624608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]